Avalo Therapeutics, Inc. - stock earnings
AVTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -5.2 million USD | 236000 USD |
| 2023Q2 | -8.2 million USD | 643000 USD |
| 2023Q1 | -10.0 million USD | 475000 USD |
| 2022Q4 | -9.8 million USD | 896000 USD |
| 2022Q3 | 3.2 million USD | 14.9 million USD |
| 2022Q2 | -13.0 million USD | 1.0 million USD |
| 2022Q1 | -22.1 million USD | 1.2 million USD |
| 2021Q4 | -19.2 million USD | 219000 USD |
| 2021Q3 | -17.4 million USD | 1.4 million USD |
| 2021Q2 | -17.1 million USD | 3.4 million USD |
| 2021Q1 | -30.7 million USD | 473000 USD |
| 2020Q4 | -15.6 million USD | 1.5 million USD |
| 2020Q3 | -13.5 million USD | 1.1 million USD |
| 2020Q2 | -13.3 million USD | 1.3 million USD |
| 2020Q1 | -21.1 million USD | 2.8 million USD |
| 2019Q4 | 1.6 million USD | -8.7 million USD |
| 2019Q3 | -4.0 million USD | 5.6 million USD |
| 2019Q2 | -6.2 million USD | 4.4 million USD |
| 2019Q1 | -7.5 million USD | 5.4 million USD |
| 2018Q4 | -5.6 million USD | 5.0 million USD |
| 2018Q3 | -24.6 million USD | 4.1 million USD |
| 2018Q2 | -6.0 million USD | 4.8 million USD |
| 2018Q1 | -3.1 million USD | 2.2 million USD |
| 2017Q3 | 18.7 million USD | 25.0 million USD |
| 2017Q2 | -1.8 million USD | 157800 USD |
| 2017Q1 | -2.0 million USD | 384206 USD |
| 2016Q4 | -1.6 million USD | 182000 USD |
| 2016Q3 | -6.2 million USD | 321497 USD |
| 2016Q2 | -3.5 million USD | 650488 USD |
| 2016Q1 | -5.1 million USD | ? USD |
| 2015Q4 | -3.6 million USD | ? USD |
| 2015Q3 | -691081 USD | ? USD |
| 2015Q2 | -2.9 million USD | ? USD |
| 2015Q1 | -3.2 million USD | ? USD |
| 2014Q4 | -2.5 million USD | ? USD |
| 2014Q3 | -5.8 million USD | ? USD |
| 2014Q2 | -4.1 million USD | ? USD |
| 2014Q1 | -3.6 million USD | ? USD |
AVTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -33.2 million USD | 2.2 million USD |
| 2022 | -41.7 million USD | 18.1 million USD |
| 2021 | -84.3 million USD | 5.4 million USD |
| 2020 | -64.4 million USD | 6.7 million USD |
| 2019 | -16.3 million USD | 6.8 million USD |
| 2018 | -40.1 million USD | 18.3 million USD |
| 2017 | 11.9 million USD | 27.8 million USD |
| 2016 | -16.5 million USD | 1.2 million USD |
| 2015 | -10.5 million USD | ? USD |
| 2014 | -16.1 million USD | ? USD |
| 2013 | -13.0 million USD | ? USD |
AVTX
Price: $16
52 week price:
Earnings Per Share: -480.00 USD
P/E Ratio: -0.01
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 45800
Market Capitalization: 12.6 million